Meihua International Medical Technologies Co., Ltd.
meihuamed.comWhat Do They Do?
Distributes disposable medical devices sourced from other manufacturers and sells its own-brand devices to healthcare providers and domestic and export distributors.
20-F for FY2025, filed Apr 29, 2026Yangzhou Huada Medical Device Co., Ltd., or Yangzhou Huada: a subsidiary wholly owned by Kang Fu International Medical and established in…View ↗
Jiangsu Yada Technology Group Co., Ltd., or Jiangsu Yada: a subsidiary wholly owned by Yangzhou Huada and established in Yangzhou, Jiangsu…View ↗
Jiangsu Huadong Medical Device Industrial Co., Ltd., or Jiangsu Huadong: a subsidiary wholly owned by Jiangsu Yada and established in…View ↗
We have three types of customers, i) direct end user customers, which includes hospitals, pharmacies and medical institutions, ii) domestic…View ↗
How Do They Make Money?
Medical-device buyers pay for disposable devices after delivery, typically within 90 days; SaaS customers pay in installments tied to project milestones as customized work progresses.
20-F for FY2025, filed Apr 29, 2026Delivery method and payment terms. Payments are typically due within 90 days after delivery in products sales; payments are made in…View ↗
Revenue from product sales is recognized at the point in time control of the products is transferred, generally upon customer receipt based…View ↗
The Company started to introduce SaaS development service to its customers in 2025. The contract term for SaaS development service is…View ↗
-
20-F for FY2025, filed Apr 29, 2026
FY2025 revenue by product or service ↗
$61.8M
-
20-F for FY2025, filed Apr 29, 2026
$61.8M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Produced
Sold outright
20-F for FY2025, filed Apr 29, 2026 |
44%
FY2022: 49%
|
Produced, FY2025
$27.3M Sources
|
Sold outright |
|
Purchased
Sold outright
20-F for FY2025, filed Apr 29, 2026 |
56%
FY2022: 51%
|
Purchased, FY2025
$34.5M Sources
|
Sold outright |
Who Are Their Customers?
Hospitals, pharmacies and medical institutions buy directly through the company's sales team and independent agents; domestic and export distributors also buy products and resell them to end users.
20-F for FY2025, filed Apr 29, 2026We have three types of customers, i) direct end user customers, which includes hospitals, pharmacies and medical institutions, ii) domestic…View ↗
We market and sell our products through multiple channels: (1) through direct sales force, including our own employees and independent…View ↗
As of the date of this Annual Report, we have a large number of independent sales agents for the marketing and sales of our products in the…View ↗
As of the date of this Annual Report, we have 4,409 domestic distributors and 403 exporting distributors. Distributors usually purchase…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 11 cents of every revenue dollar as net income in FY2025 and turned 1 cent into free cash flow.
20-F for FY2025, filed Apr 29, 2026
$8.3MView ↗
20-F for FY2025, filed Apr 29, 2026
$6.8MView ↗
20-F for FY2025, filed Apr 29, 2026
$554.3KView ↗
How Are They Changing?
Who Do They Compete With?
Competes with Shandong Weigao Group Medical Polymer, Jiangxi Hongda Medical Equipment Group, Henan Tuoren Medical Device, Allmed Medical Products, Jiangxi Sanxin Medtec, Jiangxi 3L Products Group, and Hubei Allmed
20-F for FY2025, filed Apr 29, 2026Shandong Weigao Group Medical Polymer Co., Limited, is principally engaged in the research and development, production and sale of…View ↗
Loading...
